Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
CJ-15314 by HK inno.N for Rheumatoid Arthritis: Likelihood of Approval
CJ-15314 is under clinical development by HK inno.N and currently in Phase I for Rheumatoid Arthritis. According to GlobalData, Phase...
Data Insights
CJ-15314 by HK inno.N for Psoriasis: Likelihood of Approval
CJ-15314 is under clinical development by HK inno.N and currently in Phase I for Psoriasis. According to GlobalData, Phase I...